Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline Practice Committee of the American Society for Reproductive Medicine

被引：259

作者：

Pfeifer, Samantha ^{[1
]}

Butts, Samantha ^{[1
]}

Dumesic, Daniel ^{[1
]}

Fossum, Gregory ^{[1
]}

Gracia, Clarisa ^{[1
]}

La Barbera, Andrew ^{[1
]}

Mersereau, Jennifer ^{[1
]}

Odem, Randall ^{[1
]}

Paulson, Richard ^{[1
]}

Penzias, Alan ^{[1
]}

Pisarska, Margareta ^{[1
]}

Rebar, Robert ^{[1
]}

Reindollar, Richard ^{[1
]}

Rosen, Mitchell ^{[1
]}

Sandlow, Jay ^{[1
]}

Vernon, Michael ^{[1
]}

Widra, Eric ^{[1
]}

机构：

[1] Amer Soc Reprod Med, Birmingham, AL USA

来源：

FERTILITY AND STERILITY | 2016年 / 106卷 / 07期

关键词：

IN-VITRO FERTILIZATION; ENDOTHELIAL GROWTH-FACTOR; FOLLICLE-STIMULATING-HORMONE; RANDOMIZED CONTROLLED-TRIAL; FINAL OOCYTE MATURATION; HIGH-RISK PATIENTS; INTRAVENOUS ALBUMIN; GNRH AGONIST; DOUBLE-BLIND; ANTAGONIST GANIRELIX;

D O I：

10.1016/j.fertnstert.2016.08.048

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian hyperstimulation syndrome (OHSS) is an uncommon but serious complication associated with assisted reproductive technology (ART). This systematic review aims to identify who is at high risk, how to prevent OHSS, and the treatment for existing OHSS. ((C) 2016 by American Society for Reproductive Medicine.)

引用

收藏

页码：1634 / 1647

页数：14

相关论文

共 113 条

[1] Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report [J].

Abramov, Y ;

Fatum, M ;

Abrahamov, D ;

Schenker, JG .

FERTILITY AND STERILITY, 2001, 75 (06) :1228-1230

[2] Gonadotrophin-releasing hormone antagonists for assisted reproductive technology [J].

Al-Inany, Hesham G. ;

Youssef, Mohamed A. F. M. ;

Aboulghar, Mohamed ;

Broekmans, Frank ;

Sterrenburg, Monique ;

Smit, Janine ;

Abou-Setta, Ahmed M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (05)

[3] Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients [J].

Al-Shawaf, T ;

Zosmer, A ;

Hussain, S ;

Tozer, A ;

Panay, N ;

Wilson, C ;

Lower, AM ;

Grudzinskas, JG .

HUMAN REPRODUCTION, 2001, 16 (01) :24-30

[4] Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].

Alvarez, Claudio ;

Marti-Bonmati, Luis ;

Novella-Maestre, Edurne ;

Sanz, Roberto ;

Gomez, Raul ;

Fernandez-Sanchez, Manuel ;

Simon, Carlos ;

Pellicer, Antonio .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937

[5]

Amir H, 2015, J REPROD MED, V60, P48

[6] Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization [J].

Aramwit, Pornanong ;

Pruksananonda, Kamthorn ;

Kasettratat, Narat ;

Jammeechai, Karnphat .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (12) :1148-1153

[7] Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model [J].

Ashrafi, Mahnaz ;

Bahmanabadi, Akram ;

Akhond, Mohammad Reza ;

Arabipoor, Arezoo .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (05) :1145-1152

[8] Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study [J].

Bellver, J ;

Muñoz, EA ;

Ballesteros, A ;

Soares, SR ;

Bosch, E ;

Simón, C ;

Pellicer, A ;

Remohí, J .

HUMAN REPRODUCTION, 2003, 18 (11) :2283-2288

[9] The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial [J].

Ben-Chetrit, A ;

Eldar-Geva, T ;

Gal, M ;

Huerta, M ;

Mimon, T ;

Algur, N ;

Diamant, YZ ;

Margalioth, EJ .

HUMAN REPRODUCTION, 2001, 16 (09) :1880-1884

[10] OVARIAN HYPERSTIMULATION SYNDROME - A REVIEW OF PATHOPHYSIOLOGY [J].

BERGH, PA ;

NAVOT, D .

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1992, 9 (05) :429-438

← 1 2 3 4 5 6 7 8 9 10 →